Krka, d. d. (LJSE: KRKG)
Health Care · Pharmaceuticals · SI
€260.00
+0.19% today · +30.7% 1Y
Krka, d. d. (LJSE: KRKG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.19B.
Over the last twelve months the share price has gained 30.7%, trading between 174.00 and 270.00.
Tweenvest scores Krka, d. d. across four factors: quality 87/100, value 21/100, growth 60/100, dividend 100/100. Its strongest factor is dividend.
KRKG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.19B
- Revenue (TTM)
- $2.41B
- P/E
- 18.92
- EPS
- 13.75
- Dividend yield
- 3.51%
- Beta (5Y)
- 0.44
- 52-week high
- €270.00
- 52-week low
- €174.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.28M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.